New Market Study Published: Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Review, H1 2013
Global Markets Direct's, 'Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection. Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Review, Half...
View full press release